These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3626199)

  • 1. Pharmacokinetic profiles and temporal changes in quantitative EEG after imipramine administrations.
    Morita Y; Iwaya N; Shinkuma D; Miyoshi K
    Jpn J Psychiatry Neurol; 1987 Mar; 41(1):77-85. PubMed ID: 3626199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of the route of administration of imipramine on imipramine and desipramine blood levels.
    Rigal J; Albin H; Fança X; Demotes-Mainard F; Vinçon G
    J Clin Psychopharmacol; 1989 Oct; 9(5):364-7. PubMed ID: 2677063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pattern of physical symptom changes in major depressive disorder following treatment with amitriptyline or imipramine.
    Casper RC; Katz MM; Bowden CL; Davis JM; Koslow SH; Hanin I
    J Affect Disord; 1994 Jul; 31(3):151-64. PubMed ID: 7963067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated plasma tricyclic levels with therapeutic doses of imipramine.
    Garvey MJ; Tuason VB; Johnson RA; Valentine RH; Cooper TB
    Am J Psychiatry; 1984 Jul; 141(7):853-6. PubMed ID: 6731633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of plasma imipramine-desipramine concentrations in patients receiving concomitant fluphenazine decanoate.
    Siris SG; Adan F; Lee A; Cooper TB; Mandeli J; Casey E
    J Clin Psychiatry; 1988 Feb; 49(2):64-5. PubMed ID: 3338977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of graded allele-specific changes in CYP2D6 function with imipramine dose requirement in a large group of depressed patients.
    Schenk PW; van Fessem MA; Verploegh-Van Rij S; Mathot RA; van Gelder T; Vulto AG; van Vliet M; Lindemans J; Bruijn JA; van Schaik RH
    Mol Psychiatry; 2008 Jun; 13(6):597-605. PubMed ID: 17667959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imipramine metabolism in recurrent depressive episodes.
    Tollefson G; Valentine R; Garvey M; Tuason VB
    J Affect Disord; 1985; 8(2):183-6. PubMed ID: 3157729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluvoxamine-induced alterations in plasma concentrations of imipramine and desipramine in depressed patients.
    Spina E; Pollicino AM; Avenoso A; Campo GM; Caputi AP
    Int J Clin Pharmacol Res; 1993; 13(3):167-71. PubMed ID: 8225700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Imipramine-desipramine association in depressive syndromes: EEG study during spontaneous sleep].
    Rizzitelli F; Spina A
    Acta Neurol (Napoli); 1973; 28(5):580-7. PubMed ID: 4363739
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical implications of imipramine plasma levels for depressive illness.
    Glassman AH; Perel JM; Shostak M; Kantor SJ; Fleiss JL
    Arch Gen Psychiatry; 1977 Feb; 34(2):197-204. PubMed ID: 843179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EEG frequency analysis in periodic endogenous depressions.
    Volavka J; Grof P; Mrklas L
    Psychiatr Neurol (Basel); 1967; 153(6):384-90. PubMed ID: 6030078
    [No Abstract]   [Full Text] [Related]  

  • 12. Changes in visual evoked potentials induced by imipramine in patients with endogenous depression.
    Endo S; Nakayama S; Kuraoka Y; Matsumura T; Kubota I; Hirose S; Nihira M; Hayashida M
    Nihon Ika Daigaku Zasshi; 1983 Aug; 50(4):480-8. PubMed ID: 6630421
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantitative EEG in the prediction of antidepressant response to imipramine.
    Knott VJ; Telner JI; Lapierre YD; Browne M; Horn ER
    J Affect Disord; 1996 Jul; 39(3):175-84. PubMed ID: 8856421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of subsensitivity to imipramine in the system of reverse serotonin uptake by thrombocytes in patients with endogenous depression].
    Brusov OS; Beliaev BS; Katasonov AB; Zlobina GP; Faktor MI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(9):96-100. PubMed ID: 3232463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression in children: relationship between plasma imipramine levels and response.
    Preskorn SH; Weller EB; Weller RA
    J Clin Psychiatry; 1982 Nov; 43(11):450-3. PubMed ID: 7174621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steady-state plasma concentrations of imipramine and desipramine in relation to S-mephenytoin 4'-hydroxylation status in Japanese depressive patients.
    Koyama E; Tanaka T; Chiba K; Kawakatsu S; Morinobu S; Totsuka S; Ishizaki T
    J Clin Psychopharmacol; 1996 Aug; 16(4):286-93. PubMed ID: 8835703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute changes in sleep-related hormone secretion of depressed patients following oral imipramine.
    Jarrett DB; Miewald JM; Kupfer DJ
    Biol Psychiatry; 1988 Sep; 24(5):541-54. PubMed ID: 3167143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of antidepressant effects by L-triiodothyronine in tricyclic nonresponders.
    Goodwin FK; Prange AJ; Post RM; Muscettola G; Lipton MA
    Am J Psychiatry; 1982 Jan; 139(1):34-8. PubMed ID: 7055275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excessive plasma concentration of tricyclic antidepressants resulting from usual doses: a report of six cases.
    Devane CL; Wolin RE; Rovere RA; Panahon NC; Sutfin TA; Jusko WJ
    J Clin Psychiatry; 1981 Apr; 42(4):143-7. PubMed ID: 7204359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steady-state plasma imipramine levels in prepubertal depressed children.
    Weller EB; Weller RA; Preskorn SH; Glotzbach R
    Am J Psychiatry; 1982 Apr; 139(4):506-8. PubMed ID: 7065300
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.